Literature DB >> 19411829

A novel player in the p53-mediated autophagy: Sestrin2.

Marcello D'Amelio1, Francesco Cecconi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19411829

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Autophagy modulation as a target for anticancer drug discovery.

Authors:  Xin Li; Huai-long Xu; Yong-xi Liu; Na An; Si Zhao; Jin-ku Bao
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

2.  Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.

Authors:  Ning Wang; Weidong Pan; Meifen Zhu; Maosheng Zhang; Xiaojian Hao; Guangyi Liang; Yibin Feng
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.

Authors:  Dan-Dan Li; Ting Sun; Xiao-Qi Wu; Shu-Peng Chen; Rong Deng; Shan Jiang; Gong-Kan Feng; Jing-Xuan Pan; Xiao-Shi Zhang; Yi-Xin Zeng; Xiao-Feng Zhu
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

4.  p53 mediates PEDF‑induced autophagy in human umbilical vein endothelial cells through sestrin2 signaling.

Authors:  Tiangui Chen; Tianbo Li; Jiangning Wang
Journal:  Mol Med Rep       Date:  2019-06-03       Impact factor: 2.952

5.  Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.

Authors:  Rudolf A Kley; Piraye Serdaroglu-Oflazer; Yvonne Leber; Zagaa Odgerel; Peter F M van der Ven; Montse Olivé; Isidro Ferrer; Adekunle Onipe; Mariya Mihaylov; Juan M Bilbao; Hee S Lee; Jörg Höhfeld; Kristina Djinović-Carugo; Kester Kong; Martin Tegenthoff; Sören A Peters; Werner Stenzel; Matthias Vorgerd; Lev G Goldfarb; Dieter O Fürst
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

6.  HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells.

Authors:  Jia-Hau Yen; Sheng-Teng Huang; Hung-Sen Huang; Yi-Chin Fong; Yi-Ying Wu; Jen-Huai Chiang; Yuan-Chih Su
Journal:  Cell Death Dis       Date:  2018-09-26       Impact factor: 8.469
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.